BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Qi J, Liu S, Liu W, Cai G, Liao G. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6. Aging (Albany NY) 2020;12:6904-27. [PMID: 32310823 DOI: 10.18632/aging.103050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhou W, Wu J, Zhu Y, Meng Z, Liu X, Liu S, Ni M, Jia S, Zhang J, Guo S. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology. BMC Complement Med Ther 2020;20:6. [PMID: 32020871 DOI: 10.1186/s12906-019-2787-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kim A, Kim BS, Yook JH, Kim BS. Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer. World J Gastroenterol 2020; 26(18): 2232-2246 [PMID: 32476789 DOI: 10.3748/wjg.v26.i18.2232] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, Parisi A, Woo Y. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017;79:1-14. [PMID: 28456089 DOI: 10.1016/j.ejca.2017.03.030] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 19.8] [Reference Citation Analysis]
5 Zhang C, Li Z, Xu L, Che X, Wen T, Fan Y, Li C, Wang S, Cheng Y, Wang X, Qu X, Liu Y. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer. BMC Cancer 2018;18:462. [PMID: 29690901 DOI: 10.1186/s12885-018-4384-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
6 Wu Q, Ma J, Meng W, Hui P. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1. Cancer Biol Ther 2020;21:17-25. [PMID: 31591939 DOI: 10.1080/15384047.2019.1647050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
7 赵梦雅, 陈虹羽, 刘月, 汪凯, 张晓丹, 张亚飞. miR-29通过调节抗凋亡蛋白Mcl-1表达参与胃癌细胞多药耐药的发生. 世界华人消化杂志 2016; 24(36): 4781-4787 [DOI: 10.11569/wcjd.v24.i36.4781] [Reference Citation Analysis]
8 Zhang H, Wang X, Huang H, Wang Y, Zhang F, Wang S. Hsa_circ_0067997 promotes the progression of gastric cancer by inhibition of miR-515-5p and activation of X chromosome-linked inhibitor of apoptosis (XIAP). Artif Cells Nanomed Biotechnol 2019;47:308-18. [PMID: 30688097 DOI: 10.1080/21691401.2018.1553787] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
9 Shim JH, Gim H, Lee S, Kim BJ. Inductions of Caspase-, MAPK- and ROS-dependent Apoptosis and Chemotherapeutic Effects Caused by an Ethanol Extract of Scutellaria barbata D. Don in Human Gastric Adenocarcinom Cells. J Pharmacopuncture 2016;19:129-36. [PMID: 27386146 DOI: 10.3831/KPI.2016.19.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
10 Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Ceresoli M, Montori G, Ansaloni L. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis. Eur J Surg Oncol. 2016;42:1261-1267. [PMID: 27134147 DOI: 10.1016/j.ejso.2016.03.035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
11 Bao H, Xu N, Li Z, Ren H, Xia H, Li N, Yu H, Wei J, Jiang C, Liu L. Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer. Medicine (Baltimore) 2017;96:e6839. [PMID: 28538373 DOI: 10.1097/MD.0000000000006839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leigh N, Solomon D, Pletcher E, Labow DM, Magge DR, Sarpel U, Golas BJ. The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 2020;18:182. [PMID: 32703239 DOI: 10.1186/s12957-020-01938-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fugazzola P, Coccolini F, Montori G, Ceresoli M, Baggi P, Costanzo A, Tomasoni M, Gregis F, Nozza S, Ansaloni L. Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis. J Gastrointest Oncol 2017;8:572-82. [PMID: 28736644 DOI: 10.21037/jgo.2017.03.11] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
14 Almora-Pinedo Y, Arroyo-Acevedo J, Herrera-Calderon O, Chumpitaz-Cerrate V, Hañari-Quispe R, Tinco-Jayo A, Franco-Quino C, Figueroa-Salvador L. Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats. Clin Exp Gastroenterol 2017;10:327-32. [PMID: 29270029 DOI: 10.2147/CEG.S142515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhang L, Li R, Chen H, Wei J, Qian H, Su S, Shao J, Wang L, Qian X, Liu B. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomedicine 2017;12:2129-42. [PMID: 28360520 DOI: 10.2147/IJN.S126016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 10.8] [Reference Citation Analysis]
16 Qiao X, Li Z, Li L, Ji C, Li H, Shi T, Gu Q, Liu S, Zhou Z, Zhou K. Preoperative T2-weighted MR imaging texture analysis of gastric cancer: prediction of TNM stages. Abdom Radiol (NY) 2021;46:1487-97. [PMID: 33047226 DOI: 10.1007/s00261-020-02802-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu S, Qiao X, Xu M, Ji C, Li L, Zhou Z. Development and Validation of Multivariate Models Integrating Preoperative Clinicopathological Parameters and Radiographic Findings Based on Late Arterial Phase CT Images for Predicting Lymph Node Metastasis in Gastric Cancer. Acad Radiol 2021:S1076-6332(21)00020-9. [PMID: 33487536 DOI: 10.1016/j.acra.2021.01.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Cao XL, Wang X, Li P, Ju W. Psychological effects of advanced care on patients received endoscopic gastric cancer resection. Medicine (Baltimore) 2019;98:e17497. [PMID: 31593116 DOI: 10.1097/MD.0000000000017497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Bracale U, Merola G, Pignata G, Andreuccetti J, Dolce P, Boni L, Cassinotti E, Olmi S, Uccelli M, Gualtierotti M, Ferrari G, De Martini P, Bjelović M, Gunjić D, Silvestri V, Pontecorvi E, Peltrini R, Pirozzi F, Cuccurullo D, Sciuto A, Corcione F. Laparoscopic gastrectomy for stage II and III advanced gastric cancer: long‑term follow‑up data from a Western multicenter retrospective study. Surg Endosc 2021. [PMID: 33877411 DOI: 10.1007/s00464-021-08505-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhao Y, Zhang J, Yang D, Tang Z, Wang Q. Feasibility of laparoscopic total gastrectomy for advanced Siewert type Ⅱ and type Ⅲ esophagogastric junction carcinoma: A propensity score-matched case-control study. Asian Journal of Surgery 2019;42:805-13. [DOI: 10.1016/j.asjsur.2018.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fan Y, Liu M, Liu A, Cui N, Chen Z, Yang Q, Su A. Depletion of Circular RNA circ_CORO1C Suppresses Gastric Cancer Development by Modulating miR-138-5p/KLF12 Axis. Cancer Manag Res 2021;13:3789-801. [PMID: 34007212 DOI: 10.2147/CMAR.S290629] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Mazzei MA, Di Giacomo L, Bagnacci G, Nardone V, Gentili F, Lucii G, Tini P, Marrelli D, Morgagni P, Mura G, Baiocchi GL, Pittiani F, Volterrani L, Roviello F. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg 2021;11:2376-87. [PMID: 34079708 DOI: 10.21037/qims-20-683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhou Y, Zhu X, Lin S, Zhu C, Wu L, Chen R, Chen Z, Li W. A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin. Int J Nanomedicine 2020;15:5073-82. [PMID: 32764937 DOI: 10.2147/IJN.S252049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zhou W, Wu C, Zhao C, Huang Z, Lu S, Fan X, Tan Y, Stalin A, You R, Liu X, Zhang J, Wu Z, Wu J. An Advanced Systems Pharmacology Strategy Reveals AKR1B1, MMP2, PTGER3 as Key Genes in the Competing Endogenous RNA Network of Compound Kushen Injection Treating Gastric Carcinoma by Integrated Bioinformatics and Experimental Verification. Front Cell Dev Biol 2021;9:742421. [PMID: 34646828 DOI: 10.3389/fcell.2021.742421] [Reference Citation Analysis]
25 Luo T, Chen W, Wang L, Zhao H. CA-125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study. Medicine (Baltimore). 2016;95:e5297. [PMID: 28002320 DOI: 10.1097/md.0000000000005297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Yun S, Koh J, Nam SK, Kwak Y, Ahn SH, Do Park J, Kim HH, Kim WH, Lee HS. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy. Cancer Immunol Immunother 2021;70:431-41. [PMID: 32785776 DOI: 10.1007/s00262-020-02694-6] [Reference Citation Analysis]
27 Beeharry MK, Ni ZT, Yang ZY, Zheng YN, Feng RH, Liu WT, Yan C, Yao XX, Li C, Yan M, Zhu ZG. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. BMC Cancer 2020;20:224. [PMID: 32183736 DOI: 10.1186/s12885-020-6701-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
28 Vetrivel P, Murugesan R, Bhosale PB, Ha SE, Kim HH, Heo JD, Kim GS. A Network Pharmacological Approach to Reveal the Pharmacological Targets and Its Associated Biological Mechanisms of Prunetin-5-O-Glucoside against Gastric Cancer. Cancers (Basel) 2021;13:1918. [PMID: 33921173 DOI: 10.3390/cancers13081918] [Reference Citation Analysis]
29 Wang D, Yu X, Wang X. High/positive expression of 5-fluorouracil metabolic enzymes predicts better response to S-1 in patients with gastric cancer: a meta-analysis. Int J Biol Markers. 2016;31:e101-e109. [PMID: 27012156 DOI: 10.5301/jbm.5000202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
30 Zhao H, Zheng Y, You J, Xiong J, Ying S, Xie L, Song X, Yao Y, Jin Z, Zhang C. Tumor suppressor role of miR-876-5p in gastric cancer. Oncol Lett 2020;20:1281-7. [PMID: 32724369 DOI: 10.3892/ol.2020.11680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wang ZY, Zhang JG. The Role of Helicobacter pylori and Serum Pepsinogen Levels in Metachronous Gastric Cancer After Endoscopic Gastrectomy. Surg Laparosc Endosc Percutan Tech 2020;30:447-50. [PMID: 32555069 DOI: 10.1097/SLE.0000000000000810] [Reference Citation Analysis]